The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Sex differences in clinical characteristics and long-term outcome in patients with heart failure: data from the KorAHF registry

  • Hyue Mee Kim (Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Hack-Lyoung Kim (Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University College of Medicine) ;
  • Myung-A Kim (Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University College of Medicine) ;
  • Hae-Young Lee (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital) ;
  • Jin Joo Park (Cardiovascular Center and Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Dong-Ju Choi (Cardiovascular Center and Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • Received : 2023.07.07
  • Accepted : 2023.09.08
  • Published : 2024.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background/Aims: Sex differences in the prognosis of heart failure (HF) have yielded inconsistent results, and data from Asian populations are even rare. This study aimed to investigate sex differences in clinical characteristics and long-term prognosis among Korean patients with HF. Methods: A total of 5,625 Korean patients hospitalized for acute HF were analyzed using a prospective multi-center registry database. Baseline clinical characteristics and long-term outcomes including HF readmission and death were compared between sexes. Results: Women were older than men and had worse symptoms with higher N-terminal pro B-type natriuretic peptide levels. Women had a significantly higher proportion of HF with preserved ejection fraction (HFpEF). There were no significant differences in in-hospital mortality and rate of guideline-directed medical therapies in men and women. During median follow-up of 3.4 years, cardiovascular death (adjusted hazard ratio [HR], 1.38; 95% confidence interval [CI], 1.07-1.78; p = 0.014), and composite outcomes of death and HF readmission (adjusted HR, 1.13; 95% CI, 1.01-1.27; p = 0.030) were significantly higher in men than women. When evaluating heart failure with reduced ejection fraction (HFrEF) and HFpEF separately, men were an independent risk factor of cardiovascular death in patients with HFrEF. Clinical outcome was not different between sexes in HFpEF. Conclusions: In the Korean multi-center registry, despite having better clinical characteristics, men exhibited a higher risk of all-cause mortality and readmission for HF. The main cause of these disparities was the higher cardiovascular mortality rate observed in men compared to women with HFrEF.

Keywords

Acknowledgement

These authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. KorAHF Investigators: Byung-Hee Oh, Myeong-Chan Cho, Jae-Joong Kim, Sang Hong Baek, Eun-Seok Jeon, Dong-Ju Choi, Youngkeun Ahn, Byung-Su Yoo, Seok-Min Kang, Shung Chull Chae, Hae-Young Lee, Hyun-Jai Cho, Kye Hun Kim, Jin-Oh Choi, Kyung-Kuk Hwang, Min-Seok Kim, Suk Min Seo, Jin Joo Park, Sang Eun Lee, Jae Yeong Cho, Se Yong Jang, Ju Hee Lee, Jaewon Oh.

References

  1. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342-1356. 
  2. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 2023;118:3272-3287. 
  3. Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J 2019;40:3859-3868c. 
  4. Postigo A, Martinez-Selles M. Sex influence on heart failure prognosis. Front Cardiovasc Med 2020;7:616273. 
  5. Sakai T, Motoki H, Suzuki S, et al. Gender difference in heart failure with preserved ejection fraction: clinical profiles, examinations, and prognosis. Heart Vessels 2022;37:1710-1718. 
  6. Gimeno-Miguel A, Gracia Gutierrez A, Poblador-Plou B, et al. Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records. BMJ Open 2019;9:e033174. 
  7. Sakata Y, Miyata S, Nochioka K, et al. Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C/D heart failure in Japan. Report from the CHART-2 study. Circ J 2014;78:428-435. 
  8. Lopez-Vilella R, Marques-Sule E, Laymito Quispe RDP, et al. The female sex confers different prognosis in heart failure: same mortality but more readmissions. Front Cardiovasc Med 2021;8:618398. 
  9. Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 2006;97:1228-1231. 
  10. Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 2003;42:2128-2134. 
  11. O'Meara E, Clayton T, McEntegart MB, et al.; CHARM Investigators. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;115:3111-3120. 
  12. Lam CS, Carson PE, Anand IS, et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 2012;5:571-578. 
  13. Dewan P, Rorth R, Raparelli V, et al. Sex-related differences in heart failure with preserved ejection fraction. Circ Heart Fail 2019;12:e006539. 
  14. Santas E, Palau P, Llacer P, et al. Sex-related differences in mortality following admission for acute heart failure across the left ventricular ejection fraction spectrum. J Am Heart Assoc 2022;11:e022404. 
  15. Sotomi Y, Hikoso S, Nakatani D, et al.; PURSUIT-HFpEF Investigators. Sex differences in heart failure with preserved ejection fraction. J Am Heart Assoc 2021;10:e018574. 
  16. Chung J, Kim HL, Kim MA, et al. Sex differences in long-term clinical outcomes in patients hospitalized for acute heart failure: a report from the Korean heart failure registry. J Womens Health (Larchmt) 2019;28:1606-1613. 
  17. Lee SE, Lee HY, Cho HJ, et al. Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean Acute Heart Failure Registry (KorAHF). Korean Circ J 2017;47:341-353. 
  18. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277-314. 
  19. Eisenberg E, Di Palo KE, Pina IL. Sex differences in heart failure. Clin Cardiol 2018;41:211-216. 
  20. Riedinger MS, Dracup KA, Brecht ML; SOLVD Investigatos. Studies of Left Ventricular Dysfunction. Quality of life in women with heart failure, normative groups, and patients with other chronic conditions. Am J Crit Care 2002;11:211-219. 
  21. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-639. 
  22. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-2216. 
  23. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259. 
  24. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84. 
  25. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2017;14:591-602. 
  26. Adams KF Jr, Sueta CA, Gheorghiade M, et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 1999;99:1816-1821. 
  27. Pina IL. A better survival for women with heart failure? It's not so simple… J Am Coll Cardiol 2003;42:2135-2138. 
  28. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350. 
  29. Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J 2012;163:430-437, 437.e1-e3. 
  30. Lansky AJ, Ng VG, Maehara A, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 2012;5(3 Suppl):S62-S72. 
  31. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004;43:2293-2299. 
  32. MacFadden DR, Crystal E, Krahn AD, et al. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med 2012;156:195-203. 
  33. Bohm M, Komajda M, Borer JS, et al.; SHIFT Investigators. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT. Eur J Heart Fail 2018;20:373-381. 
  34. Diamond J, DeVore AD. New strategies to prevent rehospitalizations for heart failure. Curr Treat Options Cardiovasc Med 2022;24:199-212. 
  35. Russo G, Rea F, Barbati G, et al. Sex-related differences in chronic heart failure: a community-based study. J Cardiovasc Med (Hagerstown) 2021;22:36-44. 
  36. Vicent L, Ayesta A, Esteban-Fernandez A, et al. Sex influence on the efficacy and safety of sacubitril/valsartan. Cardiology 2019;142:73-78. 
  37. McMurray JJV, Jackson AM, Lam CSP, et al. Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation 2020;141:338-351.